T1	Outcomes 678 686	Efficacy
T2	Outcomes 709 914	scores of erythema, scaling/hypertrophy and induration as well as pain and itching; general improvement scored by the investigator and global improvement scored by patients' assessment were also evaluated.
T3	Outcomes 972 1036	scaling/hypertrophy, pain, itching and global patient assessment
T4	Outcomes 1278 1288	induration
T5	Outcomes 1437 1462	size of the lesional area
T6	Outcomes 1555 1577	serious adverse events
